SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401708-20-000210
Filing Date
2020-11-09
Accepted
2020-11-09 16:11:00
Documents
16
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20201109.htm   iXBRL 8-K 37214
2 EX-99.1 nstg-8kex991.htm EX-99.1 200899
8 LOGO nstg-logo1.jpg GRAPHIC 29107
  Complete submission text file 0001401708-20-000210.txt   440674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20201109.xsd EX-101.SCH 2467
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nstg-20201109_cal.xml EX-101.CAL 750
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nstg-20201109_def.xml EX-101.DEF 1695
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20201109_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20201109_pre.xml EX-101.PRE 12686
9 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20201109_htm.xml XML 11178
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 201297785
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences